Together we move to a healthier future
Imagine a world without effective antimicrobials, such as antibiotics or biocides.
Antimicrobial resistance (or AMR for short) happens when harmful microbes develop the ability to survive antimicrobials such as antibiotics.
By 2050, 39M people are expected to die because of untreatable infections or AMR. Beyond human health, a US$100T economic accumulative loss is forecast for the same year.
​
Lixa has invented a scalable breakthrough technology, NeoXâ„¢, to reverse bacterial resistance. This means that existing antimicrobials can work again. If successful, this approach could move the needle on the AMR crisis by decades.
NeoXâ„¢ has the potential to shape a new antimicrobial paradigm for human health, agriculture, environment and industrial environments.
​
Breaking Antimicrobial Resistance​
​
Bacteria develop resistance in two key ways:
1. As single bacteria, they evolve new "weapons" and "defences" that enable them to escape attack from antimicrobials.
​
2. Bacteria crowd together into colonies and create a gooey, protective barrier called a biofilm. Biofilm colonies can be up to 1000 times more resistant to antimicrobials.
Imagine being able to simply switch resistance off.
That’s the power of NeoX™.
​
Lixa is ultimately focused on developing world-wide and cross-sector scalable resistance breakers that restore the effectiveness of:
-
Any antibiotic, biocide or disinfectant
-
Against any resistant bacteria
-
In any infectious disease or bacterial problem
![LIXA - October [03 10 23]-108.jpg](https://static.wixstatic.com/media/211034_15d92c7822d14aa59046936d2e0a8ec4~mv2.jpg/v1/fill/w_123,h_184,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/211034_15d92c7822d14aa59046936d2e0a8ec4~mv2.jpg)
"AMR needs to be solved in a scalable manner without drawing more resistance.
Bacteria don’t care about borders.
A real AMR solution must be scalable across any country, species, or environment.
The Lixa technology is compatible with existing antimicrobials and is expected to be scalable regardless of economic environments and living standards.
Together we can make this world a better place.
With Lixa, now we can."
Dr Maud Eijkenboom
CEO, Lixa
​